Fact-checked by Grok 2 weeks ago

Stand Up to Cancer

Stand Up to Cancer is an American nonprofit organization dedicated to accelerating cancer research and treatments through collaborative, multidisciplinary efforts, primarily funded by high-profile entertainment industry telethons and campaigns.^[1] Founded in 2008 as a division of the Entertainment Industry Foundation, a 501(c)(3) charitable organization, it leverages celebrity ambassadors and media partnerships to raise awareness and support innovative scientific projects aimed at detecting, treating, and curing all forms of cancer.^[2] Its core model emphasizes "Team Science," funding multi-institutional research teams that bring together experts from academia, industry, and clinical settings to expedite breakthroughs from lab to patient.^[3] The initiative was co-founded by nine women from the entertainment sector—Katie Couric, Sherry Lansing, Laura Ziskin, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren—who sought to harness industry resources in response to personal and widespread experiences with cancer.^[2] The inaugural Stand Up to Cancer telecast aired simultaneously on ABC, CBS, and NBC in September 2008, marking a pioneering broadcast event that raised $100 million in pledges and set the template for subsequent shows featuring performances, testimonials, and appeals.^[2] Subsequent telecasts, including the ninth in 2025 broadcast across more than 30 platforms on August 15, have continued this tradition, with additional international efforts like Stand Up to Cancer Canada launched in 2014.^[2] Stand Up to Cancer's mission is to raise public awareness and fund research that gets new therapies to patients quickly, with the ultimate aspiration to make every cancer patient a long-term survivor through early detection and effective treatments.^[4] Key programs include the Dream Teams, which support large-scale collaborations of up to 150 scientists; Innovative Research Grants for early-career investigators; and specialized initiatives like SU2C Catalyst for industry-academic partnerships and SU2C Convergence for interdisciplinary teams in fields such as biology, physics, and computing.^[3] In partnership with the American Association for Cancer Research, which manages the scientific review process, the organization has awarded grants across all cancer types, prioritizing projects with high potential for rapid clinical translation.^[3] Since 2008, Stand Up to Cancer has pledged over $800 million to cancer research, engaging more than 210 institutions, 3,100 researchers, and 126 research teams worldwide.^[1] This funding has supported over 280 clinical trials involving more than 37,000 patients and contributed to multiple major scientific breakthroughs, including foundational work leading to FDA approvals for treatments like Ibrance (palbociclib) for breast cancer and Olaparib for ovarian cancer.^[2] The organization's efforts have also advanced CAR T-cell therapies and other immunotherapies, with goals to reduce cancer deaths by 25% within five years and 50% within ten years through sustained innovation and collaboration.^[1]

Background and History

Founding and Early Development

Stand Up to Cancer (SU2C) was founded in 2008 by nine women from the entertainment and media industries, including Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, Ellen Ziffren, the late Laura Ziskin, and the late Noreen Fraser.^[2]^[5]^[6] These founders, many personally affected by cancer, sought to harness the influence and resources of the entertainment sector to accelerate innovative cancer research and improve patient outcomes.^[2] Their vision emphasized collaborative, multidisciplinary efforts to bridge the gap between scientific discoveries and clinical applications, ultimately aiming to turn cancer patients into long-term survivors.^[2] The initiative launched with a high-profile fundraising telecast on September 5, 2008, broadcast simultaneously on ABC, CBS, NBC, and several cable networks, marking an unprecedented collaboration among major broadcasters.^[7]^[8] This live, commercial-free special featured celebrity performances, survivor stories, and calls to action, drawing an estimated audience of over 16 million viewers and raising more than $100 million in pledges from individual donors, corporations, and organizations.^[9]^[10] The event not only generated immediate awareness but also established SU2C as a pivotal force in mobilizing public support for cancer research.^[2] Organizationally, SU2C was established as a 501(c)(3) nonprofit initiative under the Entertainment Industry Foundation (EIF), leveraging the EIF's infrastructure to manage operations and fundraising while focusing on grant-making for research.^[11]^[12] This structure allowed the founders to partner with the American Association for Cancer Research (AACR) as its scientific advisor, ensuring rigorous oversight of funded projects from the outset.^[2] By early 2009, SU2C transitioned to disbursing its first research grants, setting the stage for ongoing support of high-impact cancer studies.^[2]

Key Milestones and Evolution

In 2009, Stand Up to Cancer awarded its first research grants, including five inaugural Dream Teams focused on collaborative, high-impact cancer research projects and Innovative Research Grants supporting early-career investigators.^[2] These initial investments marked the organization's transition from awareness-raising to direct funding of translational science, emphasizing rapid delivery of laboratory discoveries to patient care.^[2] By 2014, Stand Up to Cancer expanded internationally with the establishment of Stand Up to Cancer Canada, extending its model of entertainment-driven fundraising and research support to a broader North American audience.^[2] That same year, groundwork from the SU2C Pediatric Cancer Dream Team contributed to advancements in CD19 CAR T-cell therapy, culminating in the FDA's 2017 approval of tisagenlecleucel (Kymriah) as the first such therapy for pediatric and young adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia.^[13]^[14] In 2016, the organization launched the SU2C Catalyst® and Convergence® programs, designed to foster interdisciplinary collaborations between academic scientists, industry experts, and clinicians to accelerate innovative therapies.^[2] Significant clinical progress continued in 2020 when research from the SU2C Colorectal Cancer Dream Team supported the FDA's approval of pembrolizumab (Keytruda) as a first-line immunotherapy for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) unresectable or metastatic colorectal cancer, offering patients an alternative to traditional chemotherapy.^[13]^[15] In 2023, a Convergence® Team utilized artificial intelligence in designing personalized RNA vaccines for cancer, with the approach demonstrating safety and immune response in a Phase I clinical trial.^[13] The following year, a Catalyst® Team trial combining preoperative radiation with immunotherapy achieved a 43% reduction in two-year relapse risk for patients with high-risk soft tissue sarcoma, influencing potential shifts in standard treatment protocols.^[16] Over its evolution from 2009 to 2025, Stand Up to Cancer has raised more than $800 million, enabling the funding of over 150 Team Science grants that prioritize collaborative efforts in cancer interception—detecting and treating the disease before it fully manifests.^[13] This growth reflects a strategic shift toward integrating cutting-edge technologies like AI and immunotherapy, while maintaining a focus on mission-driven early detection initiatives.^[2]

Mission and Objectives

Core Mission Statement

Stand Up To Cancer (SU2C) is a non-profit initiative dedicated to advancing cancer research through collaborative efforts. Its official mission is to raise awareness and fund research aimed at detecting and treating cancers, with the ultimate aspiration to cure all patients.^[17] Central to this mission is the acceleration of groundbreaking research to deliver new therapies as quickly as possible and save lives. SU2C emphasizes uniting top scientists and fostering collaborations to drive innovative treatments that transform patient outcomes.^[3] As a division of the Entertainment Industry Foundation, SU2C bridges the worlds of entertainment, science, and philanthropy to amplify its impact, leveraging high-profile events and partnerships to support research initiatives.^[17]

Strategic Goals and Focus Areas

Stand Up to Cancer's strategic goals emphasize transformative advancements in cancer care, with a primary objective to integrate early-stage detection as an essential component of standard care for all cancers. This initiative aims to shift the paradigm from reactive treatment to proactive prevention, leveraging cutting-edge technologies to identify cancers at their earliest, most treatable stages. By prioritizing accessible and scalable detection methods, the organization seeks to address disparities in cancer outcomes across diverse populations.^[18] Central to these goals are ambitious targets to reduce cancer deaths by 25% within five years and by 50% within ten years, measured from a 2025 baseline. Achieving these reductions would require widespread adoption of innovative screening and therapeutic strategies, potentially saving hundreds of thousands of lives annually through enhanced early detection and personalized treatments. These targets guide the allocation of research funding, ensuring that grant priorities align with high-impact areas that accelerate progress toward equitable cancer control.^[4]^[18] Key focus areas include the development of simple, non-invasive screening tests that detect molecular signatures of cancer, enabling routine monitoring without burdensome procedures. Additionally, the organization invests in predictive modeling powered by artificial intelligence to analyze individual cancer profiles and forecast treatment success, optimizing therapeutic decisions for better outcomes. Another priority is the advancement of therapeutic cancer vaccines, designed to train the immune system for long-term destruction of cancer cells, fostering durable remissions and reducing recurrence rates. These efforts collectively aim to build a comprehensive ecosystem for cancer prevention and cure.^[18]^[19]

Research Initiatives

Funding Programs and Grants

Stand Up to Cancer (SU2C) employs a core funding model centered on "Team Science," which prioritizes collaborative, multi-institutional research projects designed to deliver near-term benefits to cancer patients by accelerating the translation of discoveries into clinical applications.^[20] This approach emphasizes speed and impact over traditional grant cycles, with Requests for Applications (RFAs) posted as funds become available to support innovative efforts addressing critical gaps in cancer care. In 2009, SU2C awarded its first grants under this model, launching Dream Teams and Innovative Research Grants to foster breakthrough research.^[21] Key funding programs include the Dream Teams, which fund large-scale, interdisciplinary collaborations among leading researchers from diverse institutions to tackle high-priority challenges such as drug resistance and novel therapies.^[22] The Innovative Research Grants support early-career investigators pursuing high-risk, high-reward projects with strong translational potential, providing up to $750,000 over three years to independent researchers within seven years of their first faculty position.^[23] SU2C's Catalyst® program accelerates the development of clinical trials through drug repurposing and combination strategies, often in partnership with pharmaceutical companies, focusing on rapid progression from lab to patient.^[22] Complementing these, the Convergence® grants promote interdisciplinary innovation by integrating expertise from oncology, engineering, data science, and other fields to address complex problems like immunotherapy resistance.^[22] Guiding all grants are principles of innovation, collaboration, health equity, and goal-oriented progress. SU2C prioritizes bold, unconventional ideas that minimize bureaucratic hurdles, encourage teamwork across disciplines and institutions over individual competition, and advance equity by targeting underrepresented racial and ethnic minorities through diverse research teams and inclusive patient data.^[20] Projects must align with measurable milestones and undergo regular reviews to ensure alignment with patient-centered outcomes. The scope encompasses specific high-burden cancers, including pancreatic, breast, lung, and pediatric types, while supporting over 210 institutions and more than 3,100 researchers as of October 2025.^[17] Recent funding opportunities reflect these priorities, with RFAs emphasizing patient care equity and novel interventions; for instance, the 2025 Early-Stage Detection and Interception of Recurrence Challenge, with letters of intent due October 1, 2025 (passed), and full applications due January 21, 2026 for invited teams, offers up to $8 million total for transatlantic projects focused on preventing cancer relapse in diverse populations.^[24]

Scientific Impact and Achievements

Stand Up to Cancer has funded over 126 research teams as of October 2025, supporting more than 280 clinical trials that have reached over 37,000 patients with innovative therapies.^[17] These efforts have accelerated the translation of laboratory discoveries into clinical applications, particularly in immunotherapy and precision medicine, enabling faster access to potentially life-saving treatments for diverse cancer types.^[13] Key achievements include contributions to several FDA approvals stemming from funded research, such as tisagenlecleucel (Kymriah), the first CD19-targeted CAR T-cell therapy approved in 2017 for certain leukemias and lymphomas, and encorafenib combined with cetuximab, approved in 2018 for BRAF V600E-mutant metastatic colorectal cancer.^[13] In 2020, research supported by Stand Up to Cancer informed the expanded use of pembrolizumab (Keytruda) as a first-line immunotherapy for microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) colorectal cancers, marking a significant advancement in treatment for this subset.^[13] More recently, a 2023 Phase I trial of an investigational RNA vaccine for pancreatic cancer, personalized to patients' tumor neoantigens, demonstrated immune responses in early results, highlighting the potential of mRNA-based approaches.^[13] Additionally, a 2024 clinical trial funded by Stand Up to Cancer showed that adding pembrolizumab to standard preoperative chemotherapy and radiation reduced the risk of relapse by 43% in patients with two common types of soft tissue sarcoma.^[25] These initiatives have broadly advanced immunotherapy combinations, targeted therapies for genetic mutations, and early detection technologies, aligning with strategic goals for proactive cancer interception.^[26] Stand Up to Cancer has awarded over 150 Team Science grants, fostering collaborative projects that have contributed to transformative technologies, including improved screening methods that support survival rates exceeding 90% for many early-stage common cancers when detected promptly.^[22]^[3]

Awareness and Fundraising

Major Events and Telecasts

Stand Up to Cancer's primary fundraising events are its biennial televised specials, which began in 2008 and serve as high-profile roadblock broadcasts across major networks to amplify awareness and drive donations for cancer research. These one-hour programs feature celebrity performances, personal stories from cancer patients and survivors, and spotlights on researchers, creating an emotional and inspirational format that engages a broad audience. The inaugural special aired on September 5, 2008, from Los Angeles, hosted by news anchors Katie Couric, Diane Sawyer, and Brian Williams, and was simulcast on ABC, CBS, and NBC, marking a collaborative effort in the entertainment industry to combat cancer.^[27]^[28]^[29] Subsequent telecasts have followed a biennial schedule, with events in 2010 (September 10, from Sony Pictures Studios in Culver City, California), 2012 (September 7, from the Shrine Auditorium in Los Angeles), 2014 (September 5), 2016 (September 9, from Walt Disney Concert Hall in Los Angeles), 2018 (September 7, from Barker Hangar in Santa Monica, California), 2021 (August 21), and 2023 (August 19).^[30]^[31]^[32] Each special maintains the core format of live music, survivor testimonials, and scientific highlights, evolving to include diverse performers and virtual elements in later years, such as during the 2021 broadcast amid the COVID-19 pandemic. These events have collectively contributed to Stand Up to Cancer raising over $800 million in pledges for research since 2008.^[33] The ninth biennial special took place on August 15, 2025, in Nashville, Tennessee, hosted by Sheryl Crow, who also performed, and featured appearances by Dolly Parton, Jelly Roll, the Jonas Brothers, CeCe Winans, and Dan + Shay. Broadcast as a one-hour roadblock on networks including NBC at 8 p.m. ET/PT (7 p.m. CT), the event highlighted Nashville's music community alongside cancer researchers and survivors, emphasizing themes of hope and innovation in treatment.^[34]^[35]^[36] In addition to the telecasts, Stand Up to Cancer hosts annual online initiatives to sustain year-round engagement. The #Up2Us campaign, now in its fifth year as of 2025, is a month-long streamer and creator event running from August 1 to 31, partnering with the SU2C Stream Team to rally online communities for donations and awareness through live streams and content creation. Complementing this, the #UniteAcrossPlatforms fundraiser occurs annually in December, kicking off on Giving Tuesday (December 2) and extending through the month, uniting creators across digital platforms to support the organization's research mission.^[37]^[38]^[39]^[40]

Partnerships and Collaborations

Stand Up to Cancer has forged longstanding partnerships with major broadcast networks in the entertainment industry, beginning with a historic 2008 collaboration among ABC, CBS, and NBC to air its inaugural live fundraising telecast simultaneously across their platforms.^[12] This alliance has continued for subsequent telecasts, enabling broad reach and production support from industry producers and celebrities who contribute through performances, hosting, and advocacy to amplify cancer awareness efforts.^[7] In 2014, Stand Up to Cancer expanded internationally through a partnership establishing Stand Up to Cancer Canada, an initiative led by the Entertainment Industry Foundation Canada in collaboration with Canadian broadcasters and the American Association for Cancer Research to fund research dream teams and extend fundraising activities northward.^[2] This expansion has facilitated cross-border research funding, including support for projects like the Canadian Breast Cancer Dream Team focused on advancing breast cancer therapies.^[41] Corporate and community partnerships have integrated Stand Up to Cancer into diverse platforms, such as Major League Baseball's annual tribute during the 2025 World Series on October 25, where players, performers like the Jonas Brothers, and sponsor Mastercard paused the Dodgers-Blue Jays game to honor cancer fighters and raise funds on the field.^[42] Similarly, Raising Cane's launched a limited-edition Breast Cancer Awareness Plush Puppy campaign from October 1 to 31, 2025, donating at least $3 per $9.99 sale to support cancer research while promoting awareness through in-store and online sales.^[43] Online streaming collaborations, including the SU2C Stream Team with Twitch, empower creators to host fundraising events like the #UniteAcrossPlatforms campaign in December 2025, uniting gamers and influencers across platforms to drive donations for research.^[44] Stand Up to Cancer's research collaborations emphasize interdisciplinary "Team Science" initiatives, involving more than 210 institutions and over 3,100 scientists from academia, pharmaceutical companies, and technology sectors to accelerate translational cancer research.^[26] These ties, supported by the American Association for Cancer Research as the scientific partner, have funded over 150 team awards fostering collaborations like the 2025 partnership with SandboxAQ to innovate AI-driven treatment advancements.^[45]^[46]

References

[1]
Who We Are | Stand Up To Cancer®
Aug 19, 2025 · Stand Up To Cancer's mission is to raise awareness and fund research to detect and treat cancers with the aspiration to cure all patients. Fund ...A Life · Mission · Fund Research. Donate Today!
[2]
Our Story | Stand Up To Cancer®
Jan 29, 2025 · Stand Up To Cancer began in 2008 with nine women, each working to bring entertainment industry resources to bear in the fight against cancer.More Options · Su2c Catalyst · Major Highlights
[3]
What We Do | Stand Up To Cancer®
Stand Up To Cancer enables scientific breakthroughs by funding collaborative, multidisciplinary, multi-institutional cancer research teams and investigators.A Life · Fund Research. Donate Today! · Our Impact
[4]
Our Mission | Stand Up To Cancer®
Jul 27, 2025 · Stand Up To Cancer's mission is to raise awareness and fund research to detect and treat cancers with the aspiration to cure all patients.Stand Up To Cancer Raises... · What We Stand For · You
[5]
Stand Up to Cancer Announces More Than $80 Million Pledged So ...
The SU2C founding members include Katie Couric; Laura Ziskin, executive producer of the Sept. 5, 2008, and Sept. 10, 2010 broadcasts, who is a cancer survivor; ...
[6]
Abc, Cbs, Nbc Announce Historic Collaboration to “Stand Up To ...
May 28, 2008 · Through Stand Up To Cancer, and the September 5th broadcast, people all over the country can help,” said Zucker, who is a cancer survivor. AN ...Missing: inaugural date
[7]
Stand Up to Cancer (TV Special 2008) - IMDb
Release date · September 5, 2008 (United States) · Country of origin. United States · Language. English · Production companies · 20th Century Fox Television ...Missing: inaugural | Show results with:inaugural
[8]
Stand Up To Cancer Announces More Than $100 Million Raised in ...
Sep 8, 2008 · Stand Up To Cancer Announces More Than $100 Million Raised in Unprecedented Effort to End Cancer. Entertainment industry, corporate and ...
[9]
'Stand Up to Cancer' Raises $100M Plus - ABC News
Sep 7, 2008 · 'Stand Up to Cancer' Raises $100M Plus. Networks, activists, celebs come together to raise money for research. ByABC News.
[10]
Disclosure Statement | Stand Up To Cancer®
Jan 28, 2025 · Stand Up To Cancer (SU2C) is a California nonprofit public benefit corporation recognized as tax exempt pursuant to Section 501(c)(3) of the Internal Revenue ...
[11]
Stand Up To Cancer - Entertainment Industry Foundation
SU2C was established in 2008 by nine women in the entertainment and news industries who utilize assets of the media and entertainment community to engage ...
[12]
Portfolio and Impact | Stand Up To Cancer®
Oct 16, 2025 · The SU2C Pediatric Cancer Dream Team laid the groundwork for development of the first FDA approved CD19 CAR T therapy, tisagenlecleucel (Kymriah ...
[13]
KYMRIAH | FDA
Jul 2, 2025 · This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication ...
[14]
FDA approves pembrolizumab for first-line treatment of MSI-H ...
Jun 30, 2020 · FDA approves pembrolizumab for first-line treatment of MSI-H/dMMR colorectal cancer. On June 29, 2020, the Food and Drug Administration ...Missing: Stand | Show results with:Stand
[15]
SU2C Spotlight | Melanoma Tumors | Stand Up To Cancer®
Results showed that the addition of pembrolizumab reduced the risk of relapse by 43% at two years. The SU2C Catalyst grant that supported the trial was ...
[16]
https://standuptocancer.org/su2c-spotlight/sarcoma-clinical-trial-funded-by-stand-up-to-cancer-reduces-risk-of-relapse-by-43/
[17]
https://standuptocancer.org/
[18]
https://standuptocancer.org/science/strategy/
[19]
https://standuptocancer.org/what-we-do/our-impact/
[20]
https://standuptocancer.org/science/grant-opportunities/
[21]
Grant and Award Opportunities | Stand Up To Cancer®
Sep 16, 2025 · Stand Up To Cancer grants and awards fund cancer research projects that address critical problems in patient care and deliver near-term patient benefits.
[22]
Stand Up To Cancer Funds High-Risk/high-Reward Cancer ...
Dec 7, 2009 · Since its launch in May 2008, SU2C has raised more than $100 million from a wide range of philanthropic, corporate, and organizational donors, ...
[23]
Scientific Initiatives | Stand Up To Cancer®
Mar 31, 2025 · Stand Up To Cancer has spearheaded a range of scientific initiatives designed to revolutionize cancer research and treatment.
[24]
Stand Up To Cancer (SU2C) Innovative Research Grants (IRG)
The SU2C IRG program supports the next generation by providing substantial funding to novel, high-risk, high-reward cancer research proposals.
[25]
[PDF] program-guidelines-early-stage-detection-and-interception-of ...
Jul 15, 2025 · About Stand Up To Cancer As of April 2025, more than 3,100 scientists representing more than 210 institutions are involved in SU2C-funded ...
[26]
Stand Up To Cancer® | Fund Research. Donate Today!
Oct 3, 2025 · Stand Up To Cancer's mission is to raise awareness and fund research to detect and treat cancers with the aspiration to cure all patients.Financials · SU2C Show · Ways to Give · Who We AreMissing: total | Show results with:total
[27]
SARCOMA CLINICAL TRIAL FUNDED BY STAND UP TO CANCER ...
Jun 3, 2024 · Results showed that the addition of pembrolizumab reduced the risk of relapse by 43% at two years. The SU2C Catalyst grant that supported the ...
[28]
Science, Advances in Cancer Research | Stand Up To Cancer®
Aug 19, 2025 · Stand Up To Cancer is dedicated to improving how cancer is diagnosed and treated by focusing on early detection and cancer interception.
[29]
https://news.standuptocancer.org/press/hollywoods-stars-illuminate-su2cs-nationally-televised-fundraising-event-on-sept-7th/
[30]
Stand Up To Cancer 2010: Night Of More Than 100 Stars - CBS News
Sep 10, 2010 · Network news anchors Charles Gibson, Katie Couric and Brian Williams reported on cutting-edge cancer research that has been financed by the ...Missing: 2012 2014
[31]
Hollywood's Stars Illuminate Su2c's Nationally Televised ...
Aug 22, 2012 · The first two SU2C telecasts took place on Sept. 5, 2008 and Sept. 10, 2010, and have been viewed in more than 190 countries. To date, more than ...
[32]
Stand Up To Cancer | International Broadcasts Wiki - Fandom
Stand Up to Cancer (SU2C) is a biennial telecast that was first televised in over 170 countries on September 5, 2008. It was produced by he Entertainment ...Missing: inaugural | Show results with:inaugural
[33]
Stand Up to Cancer Broadcast September 5 2014
Jul 9, 2014 · The first three SU2C telecasts took place on September 5, 2008, September 10, 2010 and September 7, 2012, and were made available to more than ...
[34]
Stand Up To Cancer Telethon Returning Aug. 19 - Variety
Aug 10, 2023 · Founded in 2008, the program was initiated by a group of women aiming to motivate the entertainment community to raise awareness and funding for ...<|control11|><|separator|>
[35]
Impact Stories | Celebrating 15 Years of Impact | Stand Up To Cancer®
Stand Up To Cancer® (SU2C) announced that since its inception in 2008, the nonprofit has over $795 million pledged to fund critically needed cancer research.Missing: total | Show results with:total
[36]
Jelly Roll, Jonas Brothers, Cece Winans, Dan + Shay, and More ...
Aug 6, 2025 · This year's show airs Friday, August 15, at 8 p.m. ET and PT / 7 p.m. CT, marking the first time the biennial special will be broadcast from ...
[37]
2025 Stand Up To Cancer Benefit To Feature Dolly Parton, Sheryl ...
Jul 2, 2025 · The 2025 Stand Up to Cancer prime-time benefit broadcast (Aug. 14) will feature Dolly Parton and host Sheryl Crow, with more celebs to be ...
[38]
How to Watch the Stand Up to Cancer Special on NBC (2025)
Aug 5, 2025 · The Stand Up to Cancer fundraising special will air on NBC Friday, August 15, at 8/7c. The telecast will also be available to watch on Peacock, ...
[39]
#Up2Us | #SU2CStreamTeam
Sep 17, 2025 · This August, SU2C will kick off the return of our #Up2Us to Stand Up To Cancer event, a month-long collaboration to support our ...
[40]
JELLY ROLL, JONAS BROTHERS, CECE WINANS, DAN + SHAY ...
Aug 6, 2025 · As a lead-up to the televised special, SU2C has launched the #Up2Us to #StandUpToCancer campaign, which runs through Sunday, August 31. Now in ...
[41]
Featured Event | #UniteAcrossPlatforms | Stand Up To Cancer®
Join us for SU2C's #UniteAcrossPlatforms event this December! Let's Unite and help SU2C in the mission to detect, treat, and cure cancer for every patient.
[42]
#UniteAcrossPlatforms | #SU2CStreamTeam
Oct 7, 2025 · Join us for SU2C's #UniteAcrossPlatforms event this December! Let's Unite and help SU2C in the mission to detect, treat, and cure cancer for ...
[43]
SU2C Canada-Canadian Breast Cancer Foundation Breast Cancer ...
SU2C Canada and the Canadian Breast Cancer Foundation believe that this unique Breast Cancer Dream Team model will advance scientific research in the interests ...
[44]
Jonas Brothers play at World Series Stand Up to Cancer moment
Jonas Brothers add poignant touch to World Series' Stand Up to Cancer event. October 25th, 2025. Alyson Footer. @alysonfooter.
[45]
Raising Cane's launches campaign to support cancer research
Oct 1, 2025 · Raising Cane's is selling Pink Plush Puppies for $9.99 to support Stand Up To Cancer, with $3 from each sale going to cancer research.
[46]
Join #SU2CStreamTeam | Play. Stream. Raise $. Get Stuff!
SU2C Stream Team is a charity program powered by Stand Up To Cancer that empowers streamers to raise funds supporting Stand Up To Cancer and its ...Streaming For Good · Creators for Good · Partner With Us · Campaigns
[47]
Stand Up To Cancer | Scientific Partner | AACR Research Funding
The AACR is the Scientific Partner of Stand Up To Cancer, the highly successful cancer research support division of the Entertainment Industry Foundation.
[48]
Stand Up To Cancer and SandboxAQ Launch Collaboration to ...
Jun 5, 2025 · As of April 2024, more than 3,100 scientists representing more than 210 institutions are involved in SU2C-funded research projects. As SU2C's ...